Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Cooperative Allosteric Transitions01:58

Cooperative Allosteric Transitions

8.0K
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
8.0K
Conserved Binding Sites01:49

Conserved Binding Sites

4.3K
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
4.3K
Ligand Binding Sites02:40

Ligand Binding Sites

13.2K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
13.2K
Ligand Binding and Linkage00:49

Ligand Binding and Linkage

4.9K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked.  In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.9K
The Equilibrium Binding Constant and Binding Strength02:18

The Equilibrium Binding Constant and Binding Strength

13.4K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
13.4K
Chemotaxis in E. coli01:27

Chemotaxis in E. coli

95
Chemotaxis in Escherichia coli is a sensory-driven motility mechanism that enables bacteria to navigate chemical gradients, moving toward beneficial environments while avoiding harmful conditions. This process relies on a signal transduction system integrating external chemical cues with flagellar motor control.Chemoreceptors and Signal DetectionE. coli detects chemical gradients through methyl-accepting chemotaxis proteins (MCPs), which are membrane-bound chemoreceptors that sense attractants...
95

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

High-throughput automated molecular replacement for small-molecule MicroED data.

IUCrJ·2026
Same author

Conformational Trajectory of the Molecular Chameleon Grazoprevir From Formulation to Target-Bound.

Chemistry (Weinheim an der Bergstrasse, Germany)·2025
Same author

Polymorphic Structure Determination of the Macrocyclic Drug Paritaprevir by MicroED.

Advanced biology·2024
Same author

Eliminating the Missing Cone Challenge through Innovative Approaches.

bioRxiv : the preprint server for biology·2024
Same author

MicroED as a Powerful Tool for Structure Determination of Macrocyclic Drug Compounds Directly from Their Powder Formulations.

ACS chemical biology·2023
Same author

MicroED Structure of a Protoglobin Reactive Carbene Intermediate.

Journal of the American Chemical Society·2023

相关实验视频

Updated: Sep 11, 2025

A Method for Selecting Structure-switching Aptamers Applied to a Colorimetric Gold Nanoparticle Assay
12:31

A Method for Selecting Structure-switching Aptamers Applied to a Colorimetric Gold Nanoparticle Assay

Published on: February 28, 2015

15.3K

分子迷彩的适应性在目标结合中的目标结合.

Guanhong Bu1, Måns Eriksson1, Emma Rova Danelius1

  • 1Department of Chemistry, University of California Riverside, 501 Big Springs Rd., Riverside, California 92521, USA.

Structural dynamics (Melville, N.Y.)
|August 18, 2025
PubMed
概括

宏观循环,或分子驼,可以准以前无法制药的蛋白质. 它们的形状灵活性允许它们适应各种目标,有助于开发治疗肝炎C,COVID-19和癌症等疾病的药物.

科学领域:

  • 药用化学 医学化学
  • 结构生物学 结构生物学
  • 药物发现 药物发现 药物发现

背景情况:

  • 人类治疗性蛋白质的高达85%是无法通过传统的小分子来治疗的.
  • 宏观循环为调节具有挑战性的生物目标提供了潜力.
  • 这些分子表现出形状灵活性,充当"分子驼".

研究的目的:

  • 探索宏观循环在目标结合中的 conformational 适应性.
  • 研究三种已知的宏环药物:帕里塔普雷维尔,格拉索普雷维尔和西梅普雷维尔.
  • 评估与药物载体和COVID-19相关蛋白质的结合.

主要方法:

  • 实验水晶,溶液和目标结合结构的分子对接.
  • 对蛋白质结合时的形状变化的分析.
  • 在多个蛋白质标之间进行比较.

主要成果:

  • 宏环核的构造类决定了整体的药构造.
  • 这种"黑团"会影响蛋白质结合所需的形状变化.
  • 确定了与药物载体和病毒蛋白相关的特定结合模式.

结论:

更多相关视频

Measuring TCR-pMHC Binding In Situ using a FRET-based Microscopy Assay
19:05

Measuring TCR-pMHC Binding In Situ using a FRET-based Microscopy Assay

Published on: October 30, 2015

12.5K
Mapping Molecular Diffusion in the Plasma Membrane by Multiple-Target Tracing MTT
12:19

Mapping Molecular Diffusion in the Plasma Membrane by Multiple-Target Tracing MTT

Published on: May 27, 2012

17.4K

相关实验视频

Last Updated: Sep 11, 2025

A Method for Selecting Structure-switching Aptamers Applied to a Colorimetric Gold Nanoparticle Assay
12:31

A Method for Selecting Structure-switching Aptamers Applied to a Colorimetric Gold Nanoparticle Assay

Published on: February 28, 2015

15.3K
Measuring TCR-pMHC Binding In Situ using a FRET-based Microscopy Assay
19:05

Measuring TCR-pMHC Binding In Situ using a FRET-based Microscopy Assay

Published on: October 30, 2015

12.5K
Mapping Molecular Diffusion in the Plasma Membrane by Multiple-Target Tracing MTT
12:19

Mapping Molecular Diffusion in the Plasma Membrane by Multiple-Target Tracing MTT

Published on: May 27, 2012

17.4K
  • 宏观周期的结构性适应性是它们广泛的目标参与的关键.
  • 洞察力为宏观循环疗法的合理药物优化指导.
  • 为重新利用C型肝炎抑制剂用于COVID-19和癌症治疗提供了基础.